Publications
2021
2.
Daskalakis, Andreas; Brisimis, Vasilis; Grammatopoulou, Eirini; Smyrli, Eleni; Chaniotou, Aikaterini
Validity and reliability evidence of the general self-efficacy scale in Greek patients with COPD Conference
vol. 58, no. suppl 65, European Respiratory Society, 2021, ISSN: 0903-1936.
Abstract | Links | BibTeX | Tags: Behavioral science, COPD - management, quality of life
@conference{DaskalakisPA3907,
title = {Validity and reliability evidence of the general self-efficacy scale in Greek patients with COPD},
author = {Andreas Daskalakis and Vasilis Brisimis and Eirini Grammatopoulou and Eleni Smyrli and Aikaterini Chaniotou},
url = {https://erj.ersjournals.com/content/58/suppl_65/PA3907},
doi = {10.1183/13993003.congress-2021.PA3907},
issn = {0903-1936},
year = {2021},
date = {2021-01-01},
journal = {European Respiratory Journal},
volume = {58},
number = {suppl 65},
publisher = {European Respiratory Society},
abstract = {Background: Self-efficacy is associated with functional capacity and quality of life in Chronic Obstructive Pulmonary Disease (COPD) patients.Aims and Objectives: The present study was designed to examine the validity and reliability of the~General Self-Efficacy scale (GSE) responses in Greek patients with COPD.Methods: The GSE scale (n=50) was examined for construct and criterion validity as well as internal consistency.Results: Principal Components Analysis (PCA) revealed a two (2) factors solution (action self-efficacy and coping self-efficacy with eigen values 1.65 and 5.31 respectively) and with 69.67% total variability. Higher GSE scores were found in the following groups: a) smokers versus non-smokers (p<0.001), b) patients without visiting the emergency department versus patients with 1-2 visits in the last year (p<0.001), c) patients with regular follow-up versus patients with follow-up only in deterioration of symptoms (p<0.001), and d) among patients of the four quarters of the BODE index (F=2.89},
keywords = {Behavioral science, COPD - management, quality of life},
pubstate = {published},
tppubtype = {conference}
}
Background: Self-efficacy is associated with functional capacity and quality of life in Chronic Obstructive Pulmonary Disease (COPD) patients.Aims and Objectives: The present study was designed to examine the validity and reliability of the~General Self-Efficacy scale (GSE) responses in Greek patients with COPD.Methods: The GSE scale (n=50) was examined for construct and criterion validity as well as internal consistency.Results: Principal Components Analysis (PCA) revealed a two (2) factors solution (action self-efficacy and coping self-efficacy with eigen values 1.65 and 5.31 respectively) and with 69.67% total variability. Higher GSE scores were found in the following groups: a) smokers versus non-smokers (p<0.001), b) patients without visiting the emergency department versus patients with 1-2 visits in the last year (p<0.001), c) patients with regular follow-up versus patients with follow-up only in deterioration of symptoms (p<0.001), and d) among patients of the four quarters of the BODE index (F=2.89
1.
Daskalakis, Andreas; Smyrli, Eleni; Eirini, Grammatopoulou; Brisimis, Vasilis; Chaniotou, Aikaterini
Validity and reliability evidence of general self-efficacy scale in Greek adults with asthma Conference
vol. 58, no. suppl 65, European Respiratory Society, 2021, ISSN: 0903-1936.
Abstract | Links | BibTeX | Tags: Asthma - management, Behavioral science, quality of life
@conference{DaskalakisPA314,
title = {Validity and reliability evidence of general self-efficacy scale in Greek adults with asthma},
author = {Andreas Daskalakis and Eleni Smyrli and Grammatopoulou Eirini and Vasilis Brisimis and Aikaterini Chaniotou},
url = {https://erj.ersjournals.com/content/58/suppl_65/PA314},
doi = {10.1183/13993003.congress-2021.PA314},
issn = {0903-1936},
year = {2021},
date = {2021-01-01},
journal = {European Respiratory Journal},
volume = {58},
number = {suppl 65},
publisher = {European Respiratory Society},
abstract = {Background: Self-efficacy is associated with asthma control and quality of life in asthma patients.Aims and Objectives: The present study was designed to examine the validity and reliability of the General Self-Efficacy scale (GSE) responses in Greek adults with asthma.Methods: The GSE (n=50) was examined through construct validity (factor analysis and differences between groups), criterion validity (concurrent and predictive validity) as well as internal consistency reliability.Results: Principal component analysis (PCA) revealed a two-factor solution (action self-efficacy and coping self-efficacy with eigen values 4.13 and 1.94 respectively) and 60.70% of explained variability. The GSE showed high internal consistency (Cronbachtextquoterights alpha=0.84). Higher GSE scores were found in the following groups: patients with controlled versus uncontrolled asthma (p<0.001), patients without versus with hyperventilation (p<0.001) and patients with mild versus moderate and severe asthma (p<0.001). Concurrent validity testing showed moderate to high positive correlations for the GSE score with Forced Expiratory Volume in 1textquoterighttextquoteright (FEV1%) (r=0.49, p<0.01), 6 Minute Walk Distance Test (6MWDT) (r=0.80, p<0.01), and Asthma Control Test (ACT) (r=0.81, p<0.01), while low to high negative correlations were found for the GSE score with age (r=-0.29, p<0.05), Nijmegen Questionnaire (NQ) (r=-0.75, p<0.01), and Borg scale as well (r=-0.77, p<0.01). Further, multiple linear regression analysis showed that the 6MWDT was the predictor variable (Beta=0.56, p<0.001) of the GSE for the specific sample of asthma patients.Conclusions: The GSE provided validity and reliability evidence for the specific Greek sample with asthma.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA314.This abstract was presented at the 2021 ERS International Congress, in session textquotedblleftPrediction of exacerbations in patients with COPDtextquotedblright.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).},
keywords = {Asthma - management, Behavioral science, quality of life},
pubstate = {published},
tppubtype = {conference}
}
Background: Self-efficacy is associated with asthma control and quality of life in asthma patients.Aims and Objectives: The present study was designed to examine the validity and reliability of the General Self-Efficacy scale (GSE) responses in Greek adults with asthma.Methods: The GSE (n=50) was examined through construct validity (factor analysis and differences between groups), criterion validity (concurrent and predictive validity) as well as internal consistency reliability.Results: Principal component analysis (PCA) revealed a two-factor solution (action self-efficacy and coping self-efficacy with eigen values 4.13 and 1.94 respectively) and 60.70% of explained variability. The GSE showed high internal consistency (Cronbachtextquoterights alpha=0.84). Higher GSE scores were found in the following groups: patients with controlled versus uncontrolled asthma (p<0.001), patients without versus with hyperventilation (p<0.001) and patients with mild versus moderate and severe asthma (p<0.001). Concurrent validity testing showed moderate to high positive correlations for the GSE score with Forced Expiratory Volume in 1textquoterighttextquoteright (FEV1%) (r=0.49, p<0.01), 6 Minute Walk Distance Test (6MWDT) (r=0.80, p<0.01), and Asthma Control Test (ACT) (r=0.81, p<0.01), while low to high negative correlations were found for the GSE score with age (r=-0.29, p<0.05), Nijmegen Questionnaire (NQ) (r=-0.75, p<0.01), and Borg scale as well (r=-0.77, p<0.01). Further, multiple linear regression analysis showed that the 6MWDT was the predictor variable (Beta=0.56, p<0.001) of the GSE for the specific sample of asthma patients.Conclusions: The GSE provided validity and reliability evidence for the specific Greek sample with asthma.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA314.This abstract was presented at the 2021 ERS International Congress, in session textquotedblleftPrediction of exacerbations in patients with COPDtextquotedblright.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).